Galectin Therapeutics reported $33.62M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Bristol Myers Squibb BMY:US $ 100357M 2677M
Galectin Therapeutics GALT:US $ 33.62M 8.21M
Gilead Sciences GILD:US $ 62870M 210M
Idera Pharmaceuticals IDRA:US $ 26.31M 3.83M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
Regulus Therapeutics RGLS:US $ 60.98M 7.47M
Vital Therapies VTL:US $ 138.66M 11.26M
YTE INCY:US $ 5319.04M 264.81M